top of page
young-doctor-making-sure-little-girl-is-fine-after-vaccination.jpg

GlomCon's Clinical Trial Portal

A platform to help HOPE 
find OPPORTUNITY

Clinical Trials

A list of currently enrolling clinical studies

1

APOL1-mediated kidney disease​

4

Membranous
Nephropathy

7

Minimal Change Disease

2

IgA Nephropathy​
 

5

Complement 3 Glomerulopathy​

3

Lupus Nephritis
 

6

Focal segmental glomerulosclerosis​

Background movie of science technology. Electronic circuit..jpg

Selected Clinical Trials

Atypical Hemolytic Uremic Syndrome

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy (APPELHUS).

C3 Glomerulopathy

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. (APPEAR-C3G).

IC-MPGN

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (APPARENT).

IgA Nephropathy

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE-IgAN).

GlomCon's Corporate Supporters

We gratefully acknowledge the support and partnership of corporations dedicated to improving the lives of patients with glomerular diseases. 

The support from our corporate members and our strategic partners allows us to come up with bold ideas and helps us pursue our mission.

Travere Therapeutics Supporter
Novartis supporter
1200px-Vertex_logo.svg.png
image.png
Calliditas Logo.webp

EnrollMyPatient Team

Manasi Bapat.png

Dr. Manasi Bapat

Editor in Chief

Jithu Kurian.png

Dr. Jithu Kurian

Deputy Editor

Priti Meena.png

Dr. Priti Meena

Deputy Editor
Infographics editor

Anjana Gopal.png

Dr. Anjana Gopal

Deputy Editor

Rica Pitogo.png

Rica Pitogo

Website Design

bottom of page